Keratin expression in equine normal epidermis and cutaneous papillomas using monoclonal antibodies.

The research investigates the expression of keratin in normal and unhealthy skin cells of horses, specifically papillomas, using three monoclonal antibodies. The study uncovers differences between healthy and diseased cells, potentially providing new insights for the condition’s treatment.

Research Methods

• The scientific approach involved the comparison of keratin expressions in normal horse skin and those in experimentally induced equine papillomas (non-cancerous growths akin to warts).
• This comparison was made utilizing immunohistochemical methods and three different human cytokeratin monoclonal antibodies: 34 beta B4, 34 beta E12, and 35 beta H11. These antibodies bind specifically to cytokeratin, thereby helping to visualize its presence and distribution.
• Techniques involved in this research also included electron microscopy, allowing the study of cellular structure and keratinocyte alterations in the advanced stages of papilloma in great detail.

Key Findings

• The staining patterns of normal horse skin did not differ from human skin when 34 beta B4 and 34 beta E12 antibodies were used. This consistency suggests comparable keratin expression in the normal epidermis of both species.
• In contrast, keratinocytes in early-developing papilloma showed abnormal patterns and traced the presence of an extra 56 kD keratin protein using the 34 beta E12 antibody. This noticeable shift implies altered keratin expression during disease onset.
• Moreover, in the later stages of papilloma, cytolytic cells (cells that destroy other cells) in the outer layers failed to stain positively with any of the applied antibodies, indicating a lack of keratin expression.
• There were significant differences in staining patterns with the 35 beta H11 antibody between human and horse healthy skin. The 54 kD keratin protein was expressed in the upper layers of both the normal and papillomatous horse skin, presenting a unique feature of horse epidermis.

Implications and Conclusions

• The divergence in keratin expression patterns in early and advanced papillomas suggests disruptions in both the proliferation and functional terminal differentiation of keratinocytes, the main epidermal cells producing keratin.
• These alterations might be linked to the progression of papilloma within the horse skin.
• The identification of a unique “permanent” keratin marker for horse skin – the 54 kD protein – could facilitate future research into equine skin health and disease.